Cancer cell necrosis by autoschizis: Synergism of antitumor activity of vitamin C: Vitamin K3 on human bladder carcinoma T24 cells

Scanning

Volumn 20, Issue 8, 1998, Pages 564-575

  Gilloteaux, J ^a   Jamison, J M ^b   Arnold, D ^c   Ervin, E ^d   Eckroat, L ^c   Docherty, J J ^d   Neal, D ^e   Summers, J L ^b  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c BEHREND COLLEGE   (United States)

^d Northeastern Ohio Medical University   (United States)

^e AKRON CHILDREN'S HOSPITAL   (United States)

Author keywords

Bladder; Cancer; Necrosis; Ultrastructure; Vitamins

Indexed keywords

ASCORBIC ACID; MENADIONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL DEATH; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; OXIDATIVE STRESS; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 0032422047     PISSN: 01610457     EISSN: None     Source Type: Journal    
DOI: 10.1002/sca.4950200805     Document Type: Article

References (62)

1. Al-Abdulla NA, Martin LJ: Apoptosis of retrogradely degenerating neurons occurs in association with the accumulation of perikaryal mitochondria and oxidative damage to the nucleus. Am J Pathol 153, 447-456 (1998)
2. Anton-Culver H, Lee-Feldstein A, and Taylor TH: The association of bladder cancer risk with ethnicity, gender, and smoking. Ann Epidemiol 3, 429-433 (1993)
3. Atkinson DE: The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7, 4030-4040 (1968)
4. Bellomo G, Mirabelli F, Vairetti M, Iosi F, Mallorni W: Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells. Biochemical and immunocytochemical features. J Cell Physiol 143, 118-128 (1990)
5. Burin GJ, Gibb HJ, and Hill RN: Human bladder cancer: evidence for a potential irritation-induced mechanism. Food & Chem Toxicol 33, 785-795 (1995)
6. Buzzeo BD, Heisey DM, Messing EM: Bladder cancer in renal transplant recipients. Urology 50, 525-528 (1997)
7. De Laurenzi V, Melino G, Savini I, Annicchiarico-Petruzzelli M, Finazzi-Agro A, Avigliano L: Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines. Eur J Cancer 31, 463-466 (1995)
8. Di Menza L, Baron JC, Vieillefond A, Choudat D, Boccon-Gibod L, Zummer K: Risk factors for tumors of the bladder. Epidemiological study of 701 patients in Ile-de-France. Presse Med 21, 153-156 (1993)
9. Dini L, Coppola S, Ruzittu MT, Ghibelli L: Multiple pathways for apoptotic nuclear fragmentation. Exp Cell Res 223, 340-347 (1996)
10. 2+ thresholds that determine survival or death of energy-deprived cells. Am J Pathol 152, 231-240 (1998)
11. Droller MJ: Bladder cancer: state-of-the-art care. CA Cancer J Clin 48, 269-284 (1998)
12. Engeland A:Trends in the incidence of smoking-associated cancers in Norway, 1954-1993. Int J Cancer 68, 39-46 (1966)
13. Engeland A, Andersen A, Haldorsen T, Tretli S: Smoking habits and risk of cancer other than lung cancer: 28 years' follow-up of 26,000 Norwegian men and women. Cancer Causes Control 7, 497-506 (1996)
14. Ervin E, Jamison JM, J Gilloteaux, Docherty JJ, Summers JL: Characterization of the early events in vitamin C and K3-induced death of human bladder tumor cells. Scanning 20, 210-211 (1998)
15. Falcieri E, Gobbi P, Zamai L, Vitale M: Ultrastructural features of apoptosis. Scan Microsc 8, 653-666 (1994a)
16. Falcieri E, Zamai L, Santi S, Cinti C, Gobbi P, Bosco D, Cataldi A, Betts C, Vitale M: The behaviour of nuclear domains in the course of apoptosis. Histochemistry 102, 221-231 (1994b)
17. Fisher CG, Wachter W, Fuentecilla Perez E, Miller J, Weidner W, Dudeck J: Urologische Tumore in Deutschland. Ersterhebungen an 56,013 Fällen aus klinischen Krebsregistern. Urologie A 36, 143-150 (1997)
18. Gant TW, Rao DN, Mason RP, Cohen GM: Redox cycling and sulfhydryl arylation: Their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem Biol Interact 65, 157-173 (1988)
19. 3 combinations against human bladder carcinoma T24 cells: A cell death by autoschizis. Scanning 20, 208-209 (1998a)
20. 3 combinations against human bladder carcinoma T24 cells: A cell death by autoschizis (abstr). [ISPO'98] Cancer Detect Prevent 22(suppl 1) S-73 (1998b)
21. 3 combinations against human prostatic carcinoma cells. Scan Microsc Intern 9, 159-173 (1995)
22. Guo HR, Chiang HS, Hu H, Lipsitz SR, Monson RR: Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8, 545-550 (1997)
23. 3 combinations against human prostatic carcinoma cells. Tissue Cell 28, 687-701 (1996)
24. 3-induced oxidative stress in human prostate tumor cells: Mitochondrial ultrastructural alterations. Microsc Microanal 3 (suppl. 2), 23-24 (1997)
25. Karnovsky MJ: The ultrastructural basis of capillary permeability studied with peroxidase as a tracer. J Cell Biol 35, 213-236 (1967)
26. Kerr JFR: Shrinkage necrosis: A distinct mode of cellular death. J Pathol 105, 13-20 (1971)
27. Kerr, JFR, Wyllie AH, Currie AR: Apoptosis: A basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257 (1972)
28. Kiemeney LA, Corbergh JW, Koper NP, van der Heijden LH, Pauwels RP, Schapers RF, Verbeek AL: Bladder cancer incidence and survival in the South-Eastern part of The Netherlands, 1975-1989. Eur J Cancer 30A, 1134-1137 (1994)
29. Kubota Y, Shuin T, Kawasaki C, Hosaka M, Kitamura H, Cai R, Sakai H, Hashimoto K, Fujishima A: Photokilling of T24 human bladder cancer cells with titanium dioxide. Br J Cancer 70, 1107-1111 (1994)
30. Lamm DL, Thor DE, Harris SC, Reyna JA, Stogdill VD, Raduin HM: Bacillus Calmette-Guérin immunotherapy of superficial bladder cancer. J Urol 124, 38-40 (1980)
31. Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 48, 6-29 (1998)
32. Lawley PD: Historical origins of current concepts of carcinogenesis. Adv Cancer Res 65, 17-111 (1994)
33. Lazennik YAQ, Cole S, Cooke CA, Nelson WG, Earnshaw WC: Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol 123, 7-22 (1993)
34. Lupulescu A: Ultrastructure and cell surface studies of cancer cells following vitamin C treatment. J Cancer Res Clin Oncol 108, 230-232 (1992)
35. Lynch CF, Cohen MB: Urinary system. Cancer 75, 316-329 (1995)
36. Majno G, Joris I: Apoptosis, oncosis and necrosis. An overview of cell death. Am J Pathol 146, 3-15 (1995)
37. Malorni W, Iosi F, Mirabelli F, Bellomo G: Cytoskeleton as a target in menadione-induced oxidative stress in cultured mammalian cells: Alterations underlying surface bleb formation. Chem Biol Interact 80, 217-236 (1991)
38. 2+-dependent mechanisms. Arch Biochem Biophys 270, 478-488 (1989)
39. Momas I, Daures JP, Festy B, Bontoux J, Gremy F: Bladder cancer and black tobacco cigarette smoking. Some results from a French case-control study. Eur J Epidemiol 10, 599-604 (1994)
40. 3) treatment on human tumor cell growth in vitro. Cancer 63, 901-906 (1989)
41. Ouellet-Hellstrom R, Rench JD: Bladder cancer incidence in arylamine workers. J Occup Environment Med 38, 1239-1247 (1996)
42. Patard J, Guille F, Lobel B, Abbou CC, Chopin DK: Current state of knowledge concerning the mechanism of action of BCG. Prog Urol 8, 415-421 (1998a)
43. Patard JJ, Saint F, Velotti F, Abbou CC, Chopin DK: Immune response following intravesical bacillus Calmette-Guérin instillations in superficial bladder cancer: A review. Urol Res 26, 155-159 (1998b)
44. Prout GR Jr, Lin C-W, Benson RC, Nseyo UO, Daly JJ, Griffin PP, Kinsey J, Tian M, Lao Y, Mian Y, Chen X, Ren F, Qiao S: Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med 317, 1251-1255 (1987)
45. Reid GG, Edwards JG, Marshall GE, Sutcliffe RG, Lee WR: Microvilli elongate in response to hydrogen peroxide and to perturbations of intracellular calcium. Exp Cell Res 236, 86-93 (1997)
46. Roberg K, Ollinger K: Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 152, 1151-1156 (1998)
47. Rozanski TA, Grossman HB: Recent developments in the pathophysiology of bladder cancer. Am J Roentgenol 163, 789-792 (1994)
48. Shipley WU, Prout GR, Kaufman DS: Bladder cancer. Advances in laboratory innovations and clinical management, with emphasis on innovations allowing bladder-sparing approaches for patients with invasive tumors. Cancer 65, 675-683 (1990)
49. Skov T, Lynge E: Cancer risks and exposures to carcinogens in hair-dressers. Skin Pharm 7, 94-100 (1998)
50. Soloway MS : The management of superficial bladder cancer, with emphasis on intravesical chemotherapy. In The Management of Bladder Cancer (Ed. Rhagavan D). E. Arnold Publ., London (1988) 118-130
51. 3 vitamin pretreatment. Int J Cancer 40, 575-579 (1987)
52. 3 pretreatment in a mouse tumor resistant to oncovin. Anticancer Res 12, 1651-1654 (1987)
53. 3 in mice bearing solid transplantable tumor. Anticancer Res 16, 499-504 (1996)
54. Timberg G, Rahu M, Gornoi K, Aareleid T, Baburin A: Bladder cancer in Estonia, 1968-1992: Incidence, mortality, prevalence and survival. Scand J Urol Nephrol 31, 337-342 (1997)
55. Trump BF, Berezesky IK: The reactions of cells to lethal injury: Oncosis and necrosis - the role of calcium. In When Cells Die (Eds. Lockshin RA, Zakeri Z, Tilly JL). Wiley-Liss, Inc., New York (1998) 57-96
56. 3 on human urologie tumor cell lines. Life Sci 59, 1389-1400 (1996)
57. Vermes I, Clemens H, Steffens-Nakken H, Reutlingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labelled annexin V. J Immunol Meth 184, 39-51 (1995)
58. Ward EM, Sabbioni G, DeBord DG, Teass AW, Brown KK, Talaska GG, Roberts DR, Ruder AM, Streichert RP: Monitoring of aromatic exposures in woker at a chemical plant with a known bladder cancer excess. J Nat Cancer Inst 88, 1046-1052 (1996)
59. 3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci 52, 1797-1804 (1993)
60. Wyllie AH: Apoptosis: An overview. Br Med Bull 53, 451-465 (1997)
61. Wyllie AH, Kerr JFR, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 68, 251-306 (1980)
62. Zamai L, Falcieri E, Zauli G, Cataldi A, Vitale M: The optimal detection of apoptosis by flow cytometry depends on cell morphology. Cytometry 14, 891-897 (1993)